Outlook Therapeutics, Inc. — financial figures as filed
CIK 1649989 · 12 fiscal years on record
Every figure below is taken from a filed report through an explicit tag map and carries the tag and accession number it came from. A metric the company did not disclose is shown as —, never as zero.
Aggregates
computed from the figures belowMetrics filled
12 / 12
canonical metrics mapped from the filings
Mapping completeness
100.0%
all metrics present
Fiscal years on record
12
Quarters on record
32
Revenue change, latest year
−82.6%
against the preceding fiscal year
Revenue growth run
0 yr
consecutive years higher than the previous
Years with income above zero
0
11 years below zero on record
Revenue rank in peer group
564 / 629
by latest annual revenue
Disclosure lag
80 d
period end to filing date
Latest period end
2025-09-30
filed 2025-12-19
Periods that do not reconcile
0
four quarters against the reported year
Explainable annual analytics
latest annual period where both published inputs existRatios are arithmetic over reported SEC facts, not ratings, forecasts or investment advice.
| Metric | Value | Fiscal year | Inputs | Source tags |
|---|---|---|---|---|
| Gross margin | 4.0% | FY2025 | Gross profit: $57.2KRevenue: $1.4M | GrossProfit / RevenueFromContractWithCustomerExcludingAssessedTax |
| Operating margin | -4,744.3% | FY2025 | Operating income: -$67.1MRevenue: $1.4M | OperatingIncomeLoss / RevenueFromContractWithCustomerExcludingAssessedTax |
| Net margin | -4,416.2% | FY2025 | Net income: -$62.4MRevenue: $1.4M | NetIncomeLoss / RevenueFromContractWithCustomerExcludingAssessedTax |
| Operating cash-flow margin | -3,666.7% | FY2025 | Operating cash flow: -$51.8MRevenue: $1.4M | NetCashProvidedByUsedInOperatingActivities / RevenueFromContractWithCustomerExcludingAssessedTax |
| Return on assets | -335.9% | FY2025 | Net income: -$62.4MTotal assets: $18.6M | NetIncomeLoss / Assets |
| Return on equity | 193.9% | FY2025 | Net income: -$62.4MShareholders equity: -$32.2M | NetIncomeLoss / StockholdersEquity |
| Liabilities / assets | 273.2% | FY2025 | Total liabilities: $50.8MTotal assets: $18.6M | Liabilities / Assets |
| Cash / assets | 43.5% | FY2025 | Cash and equivalents: $8.1MTotal assets: $18.6M | CashAndCashEquivalentsAtCarryingValue / Assets |
Mapping completeness
12 of 1212 of 12 canonical metrics were filled from this company's filings through the explicit tag map. Tags outside that map are recorded and counted, and are never used as a value.
Revenue by fiscal year
annual, as filed- 2015$5.2M
- 2016$3M
- 2017$3.8M
- 2018$3.1M
- 2019$8.1M
- 2025$1.4M
Net income by fiscal year
annual, as filed- 2016-$53.3M
- 2017-$38.8M
- 2018-$30.1M
- 2019-$34.5M
- 2020-$35.2M
- 2021-$53.2M
- 2022-$66.1M
- 2023-$59M
- 2024-$75.4M
- 2025-$62.4M
Revenue by fiscal quarter
quarterly, as filed- 2016 Q2$994.9K
- 2016 Q3$494.9K
- 2017 Q1$303.1K
- 2017 Q2$303.1K
- 2017 Q3$303.1K
- 2018 Q1$771.9K
- 2018 Q2$771.9K
- 2018 Q3$771.9K
- 2019 Q1$1.1M
- 2019 Q2$641.1K
- 2019 Q3$583.8K
- 2025 Q3$1.5M
Annual figures
12 fiscal years shown| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4M | — | — | — | — | — | $8.1M | $3.1M | $3.8M | $3M | $5.2M | — |
| Gross profit | $57.2K | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | -$67.1M | -$71.7M | -$53.1M | -$63.1M | -$51.7M | -$36.8M | -$36.3M | -$29.6M | -$35.9M | -$51.8M | -$46.6M | — |
| Net income | -$62.4M | -$75.4M | -$59M | -$66.1M | -$53.2M | -$35.2M | -$34.5M | -$30.1M | -$38.8M | -$53.3M | -$47.4M | — |
| Operating cash flow | -$51.8M | -$68.8M | -$43M | -$56.7M | -$54.3M | -$31.8M | -$32.3M | -$33M | -$15.5M | -$45.5M | -$27.5M | — |
| Total assets | $18.6M | $28.8M | $32.3M | $28.5M | $22.8M | $19.7M | $17.1M | $22.3M | $20.7M | $23.7M | $35M | — |
| Total liabilities | $50.8M | $101.9M | $46.7M | $19.8M | $18.2M | $16.9M | $27.9M | $43.1M | $51.5M | $28.9M | $62.6M | — |
| Shareholders equity | -$32.2M | -$73.1M | -$14.4M | $8.7M | $4.6M | $2.8M | -$16.1M | -$25.5M | -$33.7M | -$5.2M | -$54.2M | — |
| Cash and equivalents | $8.1M | $14.9M | $23.4M | $17.4M | $14.5M | $12.5M | $8M | $1.7M | $3.2M | $2.4M | $9.1M | $2.3M |
| Shares outstanding | 53,887,233 | 23,905,635 | 260,257,517 | 227,310,572 | 176,461,628 | 127,183,109 | 28,609,995 | 72,220,351 | 24,933,944 | 22,802,778 | 9,436,294 | — |
| EPS, basic | -$1.79 | -$4.06 | -$0.24 | -$0.31 | -$0.35 | -$0.67 | -$1.98 | -$1.22 | -$1.67 | -$3.67 | -$5.43 | — |
| EPS, diluted | -$1.79 | -$4.06 | -$0.24 | -$0.31 | -$0.35 | -$0.67 | -$1.98 | -$1.22 | -$1.80 | -$3.67 | -$5.43 | — |
Quarterly figures
12 fiscal quarters shown| Metric | 2026 Q2 | 2026 Q1 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $1.5M | — | — | — | — | — | — | — | — | — |
| Gross profit | -$21.9K | -$1.2M | $1.1M | — | — | — | — | — | — | — | — | — |
| Operating income | -$14M | -$13.5M | -$15.7M | -$12.4M | -$21.6M | -$19.6M | -$18.9M | -$10.3M | -$18.1M | -$6.8M | -$15.7M | -$17M |
| Net income | -$4.5M | -$23.1M | -$20.2M | -$46.4M | $17.4M | $44.4M | -$114.3M | -$11.2M | -$20.7M | -$6.7M | -$18.7M | -$17.5M |
| Operating cash flow | — | -$14.9M | — | — | -$11M | — | — | -$13M | — | — | -$8.9M | — |
| Total assets | $21.9M | $18.2M | $22.4M | $19.1M | $17M | $47.1M | $59M | $21.7M | $44.4M | $54M | $62.7M | $38.6M |
| Total liabilities | $50.9M | $56.8M | $59.6M | $51.5M | $67.3M | $130.8M | $193.3M | $46M | $50M | $43.5M | $46.9M | $18.5M |
| Shareholders equity | -$29M | -$38.5M | -$37.2M | -$32.5M | -$50.3M | -$83.7M | -$134.2M | -$24.3M | -$5.5M | $10.5M | $15.8M | $20.1M |
| Cash and equivalents | $7.7M | $8.7M | $8.9M | $7.6M | $5.7M | $32M | $47.2M | $10.4M | $33.7M | $43.6M | $52.3M | $26M |
| Shares outstanding | 104,614,219 | 64,556,570 | 43,479,051 | 32,907,014 | 24,905,635 | 23,405,637 | 22,012,827 | 260,257,517 | 258,704,055 | 256,666,794 | 256,666,794 | 225,942,719 |
| EPS, basic | -$0.05 | -$0.38 | -$0.55 | -$1.50 | $0.72 | $1.91 | -$8.01 | -$0.04 | -$0.08 | -$0.03 | -$0.08 | -$0.08 |
| EPS, diluted | -$0.05 | -$0.38 | -$0.55 | -$1.50 | $0.72 | -$0.89 | -$8.01 | -$0.04 | -$0.08 | -$0.03 | -$0.08 | -$0.08 |
Latest figure against the peer median
all 722 companies with figures on recordAn industry classification is not on record for this company, so the comparison group is every company whose figures we hold, across all sectors. The median is stated with the group it was computed over; it is a fact about that group and nothing more.
| Metric | Latest annual figure | Peer median | Difference | Companies in group | Source tag |
|---|---|---|---|---|---|
| Revenue · FY2025 | $1.4M | $422.2M | −99.7% | 629 | RevenueFromContractWithCustomerExcludingAssessedTax |
| Gross profit · FY2025 | $57.2K | $129.2M | −100.0% | 349 | GrossProfit |
| Operating income · FY2025 | -$67.1M | -$3.8M | −1,667.1% | 591 | OperatingIncomeLoss |
| Net income · FY2025 | -$62.4M | $2.4M | −2,651.2% | 716 | NetIncomeLoss |
| Operating cash flow · FY2025 | -$51.8M | $20.1M | −357.7% | 715 | NetCashProvidedByUsedInOperatingActivities |
| Total assets · FY2025 | $18.6M | $1.1B | −98.3% | 720 | Assets |
| Total liabilities · FY2025 | $50.8M | $458.2M | −88.9% | 664 | Liabilities |
| Shareholders equity · FY2025 | -$32.2M | $301M | −110.7% | 716 | StockholdersEquity |
| Cash and equivalents · FY2025 | $8.1M | $82.6M | −90.2% | 688 | CashAndCashEquivalentsAtCarryingValue |
| Shares outstanding · FY2025 | 53,887,233 | 49,628,137 | +8.6% | 606 | CommonStockSharesOutstanding |
| EPS, basic · FY2025 | -$1.79 | $0.05 | −3,680.0% | 678 | EarningsPerShareBasic |
| EPS, diluted · FY2025 | -$1.79 | $0.03 | −7,260.0% | 678 | EarningsPerShareDiluted |
Where the numbers come from
every figure traces to a filing| Metric | Fiscal period | Period end | Filed | Form | Accession | XBRL tag |
|---|---|---|---|---|---|---|
| Revenue | FY2025 | 2025-09-30 | 2025-12-19 | 10-K | 0001104659-25-123264 | RevenueFromContractWithCustomerExcludingAssessedTax |
| Gross profit | FY2025 | 2025-09-30 | 2025-12-19 | 10-K | 0001104659-25-123264 | GrossProfit |
| Operating income | FY2025 | 2025-09-30 | 2025-12-19 | 10-K | 0001104659-25-123264 | OperatingIncomeLoss |
| Net income | FY2025 | 2025-09-30 | 2025-12-19 | 10-K | 0001104659-25-123264 | NetIncomeLoss |
| Operating cash flow | FY2025 | 2025-09-30 | 2025-12-19 | 10-K | 0001104659-25-123264 | NetCashProvidedByUsedInOperatingActivities |
| Total assets | FY2025 | 2025-09-30 | 2025-12-19 | 10-K | 0001104659-25-123264 | Assets |
| Total liabilities | FY2025 | 2025-09-30 | 2025-12-19 | 10-K | 0001104659-25-123264 | Liabilities |
| Shareholders equity | FY2025 | 2025-09-30 | 2025-12-19 | 10-K | 0001104659-25-123264 | StockholdersEquity |
| Cash and equivalents | FY2025 | 2025-09-30 | 2025-12-19 | 10-K | 0001104659-25-123264 | CashAndCashEquivalentsAtCarryingValue |
| Shares outstanding | FY2025 | 2025-09-30 | 2025-12-19 | 10-K | 0001104659-25-123264 | CommonStockSharesOutstanding |
| EPS, basic | FY2025 | 2025-09-30 | 2025-12-19 | 10-K | 0001104659-25-123264 | EarningsPerShareBasic |
| EPS, diluted | FY2025 | 2025-09-30 | 2025-12-19 | 10-K | 0001104659-25-123264 | EarningsPerShareDiluted |
Source: U.S. Securities and Exchange Commission, EDGAR company facts · as of 2025-12-19